PMC Links for Gene (Select 3821) - PMC

Links from Gene

Items: 1 to 20 of 44

<< First< Prev

Page of 3

Select item 103997161.

NKG2A and circulating extracellular vesicles are key regulators of natural killer cell activity in prostate cancer after prostatectomy

Yu‐Chuan Lu, Chen‐Hsun Ho, Jian‐Hua Hong, Ming‐Chieh Kuo, Yi‐An Liao, Fu‐Shan Jaw, Jason Chia‐Hsien Cheng, Chao‐Yuan Huang, Ko‐Ping Chang, Chung‐Hsin Chen, Jung‐An Lin, An Hsiao, Hsiu‐Ni Kung

Mol Oncol. 2023 Aug; 17(8): 1613–1627. Published online 2023 Mar 27. doi: 10.1002/1878-0261.13422

PMCID:: PMC10399716

Abstract Article PDF–1.6M

Select item 103108412.

The NK cell checkpoint NKG2A maintains expansion capacity of human NK cells

Meike Kaulfuss, Juliane Mietz, Astrid Fabri, Johannes vom Berg, Christian Münz, Obinna Chijioke

Sci Rep. 2023; 13: 10555. Published online 2023 Jun 29. doi: 10.1038/s41598-023-37779-6

PMCID:: PMC10310841

Abstract Article PDF–1.2M

Select item 93999413.

Implications of NKG2A in immunity and immune-mediated diseases

Xiaotong Wang, Huabao Xiong, Zhaochen Ning

Front Immunol. 2022; 13: 960852. Published online 2022 Aug 10. doi: 10.3389/fimmu.2022.960852

PMCID:: PMC9399941

Abstract Article PDF–686K

Select item 92997094.

NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division

Linda Borst, Marjolein Sluijter, Gregor Sturm, Pornpimol Charoentong, Saskia J. Santegoets, Mandy van Gulijk, Marit J. van Elsas, Christianne Groeneveldt, Nadine van Montfoort, Francesca Finotello, Zlatko Trajanoski, Szymon M. Kiełbasa, Sjoerd H. van der Burg, Thorbald van Hall

Int J Cancer. 2022 Feb 15; 150(4): 688–704. Published online 2021 Nov 10. doi: 10.1002/ijc.33859

PMCID:: PMC9299709

Abstract Article PDF–6.8M

Select item 89202315.

Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer

Kathleen Ducoin, Romain Oger, Linda Bilonda Mutala, Cécile Deleine, Nicolas Jouand, Juliette Desfrançois, Juliette Podevin, Emilie Duchalais, Jonathan Cruard, Houssem Benlalam, Nathalie Labarrière, Céline Bossard, Anne Jarry, Nadine Gervois-Segain

Oncoimmunology. 2022; 11(1): 2046931. Published online 2022 Mar 9. doi: 10.1080/2162402X.2022.2046931

PMCID:: PMC8920231

Abstract Article PDF–3.6M

Select item 76731176.

Epstein–Barr virus peptides derived from latent cycle proteins alter NKG2A + NK cell effector function

Berenice Mbiribindi, Josselyn K. Pena, Matthew P. Arvedson, Claudia Moreno Romero, Sarah R. McCarthy, Olivia L. Hatton, Carlos O. Esquivel, Olivia M. Martinez, Sheri M. Krams

Sci Rep. 2020; 10: 19973. Published online 2020 Nov 17. doi: 10.1038/s41598-020-76344-3

PMCID:: PMC7673117

Abstract Article PDF–3.8M

Select item 69792617.

CD8⁺ T Cells Form the Predominant Subset of NKG2A⁺ Cells in Human Lung Cancer

Yongyuan Chen, Zhongwei Xin, Lijian Huang, Lufeng Zhao, Shijie Wang, Jiwei Cheng, Pin Wu, Ying Chai

Front Immunol. 2019; 10: 3002. Published online 2020 Jan 17. doi: 10.3389/fimmu.2019.03002

PMCID:: PMC6979261

Abstract Article PDF–7.8M

Select item 35171228.

NKG2A is a marker for acquisition of regulatory function by human CD8+ T cells activated with anti-CD3 antibody

Vitaly Ablamunits, Octavian Henegariu, Paula Preston-Hurlburt, Kevan C. Herold

Eur J Immunol. Author manuscript; available in PMC 2012 Dec 7.

Published in final edited form as: Eur J Immunol. 2011 Jul; 41(7): 1832–1842. Published online 2011 Jun 6. doi: 10.1002/eji.201041258

PMCID:: PMC3517122

Abstract Article PDF–1.2M

Select item 29173529.

NK Cell Terminal Differentiation: Correlated Stepwise Decrease of NKG2A and Acquisition of KIRs

Vivien Béziat, Benjamin Descours, Christophe Parizot, Patrice Debré, Vincent Vieillard

PLoS One. 2010; 5(8): e11966. Published online 2010 Aug 6. doi: 10.1371/journal.pone.0011966

PMCID:: PMC2917352

Abstract Article PDF–3.5M

Select item 217450910.

NKG2A inhibits TH2 cell effector function in vitro

Robert J Freishtat, Bahar Mojgani, Maryam Nazemzadeh, Kanneboyina Nagaraju, Eric P Hoffman

BMC Pulm Med. 2007; 7: 14. Published online 2007 Oct 10. doi: 10.1186/1471-2466-7-14

PMCID:: PMC2174509

Abstract Article PDF–729K

Select item 211776011.

Small intestinal CD8⁺TCRγδ⁺NKG2A⁺ intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease

Govind Bhagat, Afzal J. Naiyer, Jayesh G. Shah, Jason Harper, Bana Jabri, Timothy C. Wang, Peter H.R. Green, John S. Manavalan

J Clin Invest. 2008 Jan 2; 118(1): 281–293. Published online 2007 Dec 6. doi: 10.1172/JCI30989

PMCID:: PMC2117760

Abstract Article PDF–2.4M

Select item 1110451612.

Antigen-specific memory NK cell responses against HIV and influenza utilize the NKG2/HLA-E axis

Stephanie Jost, Olivier Lucar, Esther Lee, Taylor Yoder, Kyle Kroll, Sho Sugawara, Scott Smith, Rhianna Jones, George Tweet, Alexandra Werner, Phillip J. Tomezsko, Haley L. Dugan, Joshua Ghofrani, Philippe Rascle, Marcus Altfeld, Michaela Müller-Trutwin, Paul Goepfert, R. Keith Reeves

Sci Immunol. Author manuscript; available in PMC 2024 May 20.

Published in final edited form as: Sci Immunol. 2023 Dec 8; 8(90): eadi3974. Published online 2023 Dec 8. doi: 10.1126/sciimmunol.adi3974

PMCID:: PMC11104516

Abstract Article PDF–849K

Select item 1047821113.

KLRC1 knockout overcomes HLA-E-mediated inhibition and improves NK cell antitumor activity against solid tumors

Alice Mac Donald, Delphine Guipouy, William Lemieux, Mario Harvey, Louis-Jean Bordeleau, David Guay, Hugo Roméro, Yuanyi Li, Renaud Dion, Kathie Béland, Elie Haddad

Front Immunol. 2023; 14: 1231916. Published online 2023 Aug 21. doi: 10.3389/fimmu.2023.1231916

PMCID:: PMC10478211

Abstract Article PDF–4.7M

Select item 947912214.

NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer

Bérengère Salomé, John P. Sfakianos, Daniel Ranti, Jorge Daza, Christine Bieber, Andrew Charap, Christian Hammer, Romain Banchereau, Adam M. Farkas, Dan Fu Ruan, Sudeh Izadmehr, Daniel Geanon, Geoffrey Kelly, Ronaldo M. de Real, Brian Lee, Kristin G. Beaumont, Sanjana Shroff, Yuanshuo A. Wang, Ying-chih Wang, Tin Htwe Thin, Monica Garcia-Barros, Everardo Hegewisch-Solloa, Emily M. Mace, Li Wang, Timothy O’Donnell, Diego Chowell, Ruben Fernandez-Rodriguez, Mihaela Skobe, Nicole Taylor, Seunghee Kim-Schulze, Robert P. Sebra, Doug Palmer, Eleanor Clancy-Thompson, Scott Hammond, Alice O. Kamphorst, Karl-Johan Malmberg, Emanuela Marcenaro, Pedro Romero, Rachel Brody, Mathias Viard, Yuko Yuki, Maureen Martin, Mary Carrington, Reza Mehrazin, Peter Wiklund, Ira Mellman, Sanjeev Mariathasan, Jun Zhu, Matthew D. Galsky, Nina Bhardwaj, Amir Horowitz

Cancer Cell. Author manuscript; available in PMC 2023 Sep 12.

Published in final edited form as: Cancer Cell. 2022 Sep 12; 40(9): 1027–1043.e9. doi: 10.1016/j.ccell.2022.08.005

PMCID:: PMC9479122

Abstract Article PDF–3.7M

Select item 897583515.

Downregulated cytotoxic CD8⁺ T-cell identifies with the NKG2A-soluble HLA-E axis as a predictive biomarker and potential therapeutic target in keloids

Heng Xu, Zhu Zhu, Jian Hu, Jiawei Sun, Yan Wo, Xianshu Wang, Hongzhi Zou, Bin Li, Yixin Zhang

Cell Mol Immunol. 2022 Apr; 19(4): 527–539. Published online 2022 Jan 17. doi: 10.1038/s41423-021-00834-1

PMCID:: PMC8975835

Abstract Article PDF–5.4M

Select item 885868616.

SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells

Quirin Hammer, Josefine Dunst, Wanda Christ, Francesca Picarazzi, Mareike Wendorff, Pouria Momayyezi, Oisín Huhn, Herman K. Netskar, Kimia T. Maleki, Marina García, Takuya Sekine, Ebba Sohlberg, Valerio Azzimato, Myriam Aouadi, Karolinska COVID-19 Study Group, Severe COVID-19 GWAS Group, Frauke Degenhardt, Andre Franke, Francesco Spallotta, Mattia Mori, Jakob Michaëlsson, Niklas K. Björkström, Timo Rückert, Chiara Romagnani, Amir Horowitz, Jonas Klingström, Hans-Gustaf Ljunggren, Karl-Johan Malmberg

Cell Rep. 2022 Mar 8; 38(10): 110503. Published online 2022 Feb 21. doi: 10.1016/j.celrep.2022.110503

PMCID:: PMC8858686

Abstract Article PDF–3.5M

Select item 816166417.

Potential prognostic value of PD-L1 and NKG2A expression in Indonesian patients with skin nodular melanoma

Ridwan Dwi Saputro, Hanggoro Tri Rinonce, Yayuk Iramawasita, Muhammad Rasyid Ridho, Maria Fransiska Pudjohartono, Sumadi Lukman Anwar, Kunto Setiaji, Teguh Aryandono

BMC Res Notes. 2021; 14: 206. Published online 2021 May 28. doi: 10.1186/s13104-021-05623-7

PMCID:: PMC8161664

Abstract Article PDF–1009K

Select item 654765518.

Senescent cells evade immune clearance via HLA-E-mediated NK and CD8⁺ T cell inhibition

Branca I. Pereira, Oliver P. Devine, Milica Vukmanovic-Stejic, Emma S. Chambers, Priya Subramanian, Neil Patel, Alex Virasami, Neil J. Sebire, Veronica Kinsler, Alexis Valdovinos, Claude Jourdan LeSaux, João F. Passos, Antony Antoniou, Malcom H. A. Rustin, Judith Campisi, Arne N. Akbar

Nat Commun. 2019; 10: 2387. Published online 2019 Jun 3. doi: 10.1038/s41467-019-10335-5

PMCID:: PMC6547655

Abstract Article PDF–2.0M

Select item 648633319.

Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells

Takahiro Kamiya, See Voon Seow, Desmond Wong, Murray Robinson, Dario Campana

J Clin Invest. 2019 May 1; 129(5): 2094–2106. Published online 2019 Apr 15. doi: 10.1172/JCI123955

PMCID:: PMC6486333

Abstract Article PDF–8.9M

Select item 513379820.

The Activating NKG2C Receptor Is Significantly Reduced in NK Cells after Allogeneic Stem Cell Transplantation in Patients with Severe Graft-versus-Host Disease

Lambros Kordelas, Nina-Kristin Steckel, Peter A. Horn, Dietrich W. Beelen, Vera Rebmann

Int J Mol Sci. 2016 Nov; 17(11): 1797. Published online 2016 Oct 27. doi: 10.3390/ijms17111797

PMCID:: PMC5133798

Abstract Article PDF–1.2M

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Gene

Items: 1 to 20 of 44

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity